References
- Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention, 2019. Available from: https://ginasthma.org/wp-content/uploads/2019/06/GINA-2019-main-report-June-2019-wms.pdf. Accessed May 14, 2021.
- Asthma 2020. Available from: https://www.who.int/news-room/q-a-detail/asthma. Accessed May 14, 2021.
- GBD 2015 Chronic Respiratory Disease Collaborators. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Respir Med. 2017;5:691–706.
- World Health Organization (WHO). Global surveillance, prevention, and control of chronic respiratory diseases: a comprehensive approach, 2007. Available from: https://www.who.int/gard/publications/GARD%20Book%202007.pdf. Accessed May 14, 2021.
- Bahari MB, Mohd Nur M, Rahman FAB. A knowledge of asthma in school children: a survey among primary school teachers. Singapore Med J. 2003;44:131–135.
- Quirce S, Heffler E, Nenasheva N, et al. Revisiting late-onset asthma: clinical characteristics and association with allergy. J Asthma Allergy. 2020;13:743–752.
- Dharmage SC, Perret JL, Custovic A. Epidemiology of asthma in children and adults. Front Pediatr. 2019;7:246.
- Miranda C, Busacker A, Balzar S, et al. Distinguishing severe asthma phenotypes: role of age at onset and eosinophilic inflammation. J Allergy Clin Immune. 2004;113:101–108.
- Demoly P, Annunziata K, Gubba E, et al. Repeated cross-sectional survey of patient-reported asthma control in Europe in the past 5 years. Eur Respir Rev. 2012;21:66–74.
- Patridge MR, van der Molen T, Myrseth SE, et al. Attitudes and actions of asthma patients on regular maintenance therapy: the INSPIRE study. BMC Pulm Med. 2006;6:13.
- Demoly P, Gueron B, Annunziata K, et al. Update on asthma control in five European countries: results of a 2008 survey. Eur Respir Rev. 2010;19:150–157.
- Bakri R, Mohd Said N, Mohan J, et al. Ministry of Health. Malaysia: National Health and Morbidity Survey; 1999.
- Radhakrishna N, Tay TR, Hore-Lacy F, et al. Profile of difficult to treat asthma patients referred for systematic assessment. Respir Med. 2016;117:166–173.
- Marseglia GL, Caimmi S, Marseglia A, et al. Rhinosinusitis and asthma. Int J Immunopathol Pharmacol. 2010;23:29–31.
- Adult tobacco use information. National Center for Health Statistics, Centers for Disease Control and Prevention (CDC), 2017. https://www.cdc.gov/nchs/nhis/tobacco/tobacco_glossary.htm. Accessed May 14, 2021.
- Rozlan I. The study on asthma admissions in Malaysia. Disease Control Division (NCD), Ministry of Health Malaysia. 2002;1:10–17.
- Ministry of Health, Malaysia. National health and morbidity survey: healthcare demand and out-of-pocket health expenditure, 2011. Available from: http://iku.moh.gov.my/images/IKU/Document/REPORT/NHMS2011-VolumeIII.pdf. Accessed May 14, 2021.
- Jonsson M, Egmar AC, Kiessling A, et al. Adherence to national guidelines for children with asthma at primary health centres in Sweden: potential for improvement. PrimCare Respir J. 2012;21:276–282.
- Barton C, Proudfoot J, Amoroso C, et al. Management of asthma in Australian general practice: care is still not in line with clinical practice guidelines. Prim Care Respir J. 2009;18:100–105.
- Hussain SF, Zahid S, Khan JA, et al. Asthma management by general practitioners in Pakistan. Int J Tuberc Lung Dis. 2004;8:414–417.
- Salama AA, Mohammed AA. El Okda el SE, et al. Qual Care Egypt Asthmatic Child. 2010;21(36):33.
- Yeh KW, Chiang LC, Chen SH, et al. Survey of the clinical practice of physicians in the management of asthma in Taiwan. Asian Pac J Allergy Immunol. 2006;24:1–8.
- Pedersen S. From asthma severity to control: a shift in clinical practice. Prim Care Respir J. 2010;19:3–9.
- Bateman ED, Boushey HA, Bousquet J, et al. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study. Am J Respir Crit Care Med. 2004;170:836–844.
- Lai CKW, Guia TS, Kim YY, et al. Asthma control in the Asia-Pacific region: the asthma insights and reality in Asia-Pacific study. J Allergy Clin Immunol. 2003;111:263–268.
- Zainudin BM, Lai CKW, Soriano JB, Jia-Horng W, Guia TS. Asthma Insights and Reality in Asia-Pacific (AIRIAP) Steering Committee. Asthma Contro Adults Asia Pac Respirol. 2005;10:579–586.
- Nathan RA, Thompson PJ, Price D, et al. Taking aim at asthma around the world: global results of the asthma insight and management survey in the Asia Pacific Region, Latin America, Europe, Canada, and the United States. J Allergy Clin Immunol. 2015;3:734–742.
- Rabe KF, Adachi M, Lai CK, et al. Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys. J Allergy Clin Immunol. 2004;114:40–47.
- Bellamy D, Harris T. Poor perceptions and expectations of asthma control: results of the International Control of Asthma Symptoms (ICAS) survey of patients and general practitioners. Prim Care Respir J. 2005;14:252–258.
- Price D, Fletcher M, van der Molen T. Asthma control and management in 8,000 European patients: the REcognise Asthma and Link to Symptoms and Experience (REALISE) survey. Npj Prim Care Resp Med. 2014;24:14009.
- Cheong KH, Ngiam NJ, Morgan GG, et al. Acute health impacts of the Southeast Asian transboundary haze problem – a review. Int J Environ Res Public Health. 2019;16:3286.
- Pavagadhi S, Betha R, Venkatesan S, Balasubramaniam R, Hande MP. Physicochemical and toxicological characteristics of urban aerosols during a recent Indonesian biomass burning episode. Environ Sci Pollut Res. 2013;20:2569.
- Ming CR, Ban AYL, Abdul Hamid MF, Latif TM, Mohammad N, Hassan T. Annual Southeast Asia haze increases respiratory admissions: a 2-year large single institution experience. Respirology. 2018;23:914–920.
- Chew FT, Ooi BC, Hui JK, Saharom R, Goh DY, Lee BW. Singapore’s haze and acute asthma in children. Lancet. 1995;346:1427.
- GBD Chronic Respiratory Disease Collaborators. Prevalence and attributable health burden of chronic respiratory diseases, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Respir Med. 2020;8:585–596.
- Price DB, Rigazio A, Campbell JD, et al. Blood eosinophil count and prospective annual asthma disease burden: a UK cohort study. Lancet Respir Med. 2015;3:849–858.
- Pavord ID, Korn S, Howarth P, et al. Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial. Lancet. 2012;380:651–659.
- Wenzel S, Ford L, Pearlman D, et al. Dupilumab in persistent asthma with elevated eosinophil levels. N Eng J Med. 2013;368:2455–2466.
- Melani AS, Bonavia M, Cilenti V, et al. Inhaler mishandling remains common in real life and is associated with reduced disease control. Respir Med. 2011;105:930–938.
- World Health Organization. Malaysian health system review. Health Syst Transit. 2012;2:1.